Archive · 5 Dec 2025
Healthify Expands Drugmaker Partnerships for Weight Loss
Healthify is a health-tech company that helps people track their health and get advice on nutrition and fitness.
They recently partnered with Novo Nordisk India to offer coaching services to people using Novo's weight-loss drugs.
Healthify wants to partner with more drug companies to help even more people.
They have a lot of users and expect their weight-loss program to grow a lot in the next year.
India is a big market for weight-loss treatments, and Healthify wants to be a leader in this area.
Healthify partners with Novo Nordisk India to offer health coaching for weight-loss drug users.
The company aims to expand similar partnerships with other weight-loss drugmakers.
Healthify's weight-loss initiative already accounts for a double-digit share of its revenue.
The company has 45 million global users and expects significant growth in its GLP-1 programme.
India is a key market for obesity treatments, with a potential market value of $150 million annually by 2030.
- Who
- Healthify, Novo Nordisk India, Eli Lilly, Local generic drugmakers
- What
- Healthify is expanding partnerships with weight-loss drugmakers to offer health coaching
- When
- The deal with Novo Nordisk India was signed recently, with plans to expand in the next year
- Where
- India, with potential expansion to other geographies
- Why
- To boost paid subscriber base and become a leading patient support provider for GLP-1 drug companies
- Company
- Healthify
- Partnership
- Novo Nordisk India
- Global Users
- 45 million
- Paid Subscribers
- Six-digit figures
- GLP-1 Programme Growth
- Fastest-growing offering
- Expected Subscription Growth
- More than a third from GLP-1 programme